RECURRENT GRADE 3B FOLLICULAR LYMPHOMA

Clinical trials for RECURRENT GRADE 3B FOLLICULAR LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new RECURRENT GRADE 3B FOLLICULAR LYMPHOMA trials appear

Sign up with your email to follow new studies for RECURRENT GRADE 3B FOLLICULAR LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 7 Not yet finished but already full! 1 Completed 1

Boosting the immune System's cancer fighters: new combo therapy tested for tough lymphomas

Disease control Ongoing

This early-stage trial is testing whether adding an investigational drug called NKTR-255 to an approved CAR-T cell therapy makes the treatment more effective for adults with large B-cell lymphoma that has returned or not responded to prior treatments. NKTR-255 is designed to boos…

Matched conditions: RECURRENT GRADE 3B FOLLICULAR LYMPHOMA

Phase: PHASE1 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control

Last updated Mar 18, 2026 14:41 UTC

RECURRENT GRADE 3B FOLLICULAR LYMPHOMA

Get alerted when new RECURRENT GRADE 3B FOLLICULAR LYMPHOMA trials appear

Boosting the immune System's cancer fighters: new combo therapy tested for tough lymphomas